epo

Documents about epo

• Tecnología de producción de muteínas hiperglicosiladas de eritropoyetina humana#187482Biblioteca Virtual UNL
• Detection of a Distinct Erythropoietin (EPO) Profile After Isoelectric Focusing in Patients With Familial Erythrocytosis#250342HAL (France)
• Erythropoietin (EPO) and Granulocyte-Colony Stimulating Factor (G-CSF) for Low-Risk Myelodysplastic Syndromes (MDS)#862928ClinicalTrials.gov
• Expression analysis of DDC, dACE2, and EPO genes in Moroccan COVID-19 patients: links to viral load and demographics#288294HAL (France)
• SLMAP and EPO Genetic Polymorphism in Diabetic Retinopathy#314284ClinicalTrials.gov
• Sponge and Eosinophil Peroxidase (EPO) Staining#877128ClinicalTrials.gov
• Headnotes and Catchwords of EPO Board of Appeal Decisions#174228Zenodo (CERN)
• The patccat classifier for patent claims - EPO edition#326618Mannheim Research Data
• Patent applications to the EPO by priority year (1977-2017)#814945Eurostat
• Mechanisms of EPO-induced Hypertension#435789ClinicalTrials.gov
• Visual Elements, Meanings and Social Functions in Sikka Ikat Weaving#1002631ARTic
• High-tech patent applications to the EPO by priority year (1977-2013)#814942Eurostat
• Patent applications to the EPO by priority year and metropolitan region (1977-2012)#788077Eurostat
• Patent applications to the EPO by priority year by institutional sector (1977-2012)#814930Eurostat
• Patent applications to the EPO by priority year and other typologies (1977-2012)#817597Eurostat
• Safety and Efficacy of Multiple EPO Injections in Children With Cerebral Palsy#902416ClinicalTrials.gov
• Patent applications to the EPO with foreign co-inventors, by priority year (1977-2013)#814938Eurostat
• Patent applications to the EPO by priority year by NUTS 3 region (1977-2012)#814952Eurostat
• Patent applications to the EPO by country of applicants and inventors (2004 and onwards)#814955Eurostat
• Rethinking EPO: A Paradigm Shift in Oncology?#137348HAL (France)
• High-tech patent applications to the EPO by priority year and metropolitan region (1977-2012)#788076Eurostat
• Co-patenting at the EPO according to applicants'/inventors' country of residence - number (1977-2013)#814926Eurostat
• Patent applications to the EPO by priority year by NACE Rev. 2 activity (1977-2012)#814934Eurostat
• High-tech patent applications to the EPO by priority year and other typologies (1977-2012)#817595Eurostat
• High-tech patent applications to the EPO by priority year and NUTS 3 region (1977-2012)#814950Eurostat
• Effect of Hypoxic Exposure on Blood Variables in Elite Wrestlers#848108ClinicalTrials.gov
• Patent applications to the EPO by priority year by international patent classification (IPC) sections and classes (1977-2012)#814932Eurostat
• Hydroxyurea and EPO in Sickle Cell Disease#840610ClinicalTrials.gov
• Patent applications to the EPO by priority year, international patent classification (IPC) sections, classes and other typologies (1977-2012)#817594Eurostat
• Patent applications to the EPO by priority year, by international patent classification (IPC) sections, classes and metropolitan region (1977-2012)#788075Eurostat
• Safety Study of Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Traumatic Brain Injury: Dosing Tier 1#802161ClinicalTrials.gov
• Patent applications to the EPO by priority year by NUTS 3 region, international patent classification (IPC) sections and classes (1977-2013)#814948Eurostat
• Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes#849694ClinicalTrials.gov
• Identification of New Serum Markers for Detection of Abuse With Erythropoietin#862759ClinicalTrials.gov
• Evaluation of Tolerability and Efficacy of Erythropoietin (EPO) Treatment in Spinal Shock: Comparative Study Versus Methylprednisolone (MP)#871411ClinicalTrials.gov
• Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy#805438ClinicalTrials.gov
• EU co-patenting at the EPO according to applicants'/ inventors' country of residence by international patent classification (IPC) sections - number (1977-2013)#814928Eurostat
• Patent cooperation treaty (PCT) applications designated to the EPO by priority year by international patent classification (IPC) sections and classes (1978-2013)#814936Eurostat
• Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With ERSD Receiving Maintenance Hemodialysis#906351ClinicalTrials.gov
• The Clinical Study to Evaluate Immunogenicity of Epodion® in Anemia Associated With CKD Patients#831383ClinicalTrials.gov
• Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB#873584ClinicalTrials.gov
• ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases#888550ClinicalTrials.gov
• Assessment of BHB Concentration Agreement Among Sampling Locations and the Impact of Ketosis on EPO, and More#908312ClinicalTrials.gov
• Efficacy & Safety Study of KPT-330 in Erythropoietin-Refractory Lower-Risk Myelodysplastic Syndrome Patients#853129ClinicalTrials.gov
• Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)#862496ClinicalTrials.gov
• The Effect of Preoperative Intravenous Ferric Derisomaltose and EPO and Tranexamic Acid in Patients With Preoperative Anemia or Iron Deficiency in Bone Tumor#895308ClinicalTrials.gov
• EPO-0684 Beyond objective measures: perceived environment associates with post-stroke quality of life [Abstract] / Lino Braadt, Markus Naumann, Christa Meisinger, Jakob Linseisen, Michael Ertl, Elke Hertig#661679Deutsche Nationalbibliothek
• Granulation-driven modulation of improved advanced flow properties with immediate drug release using modified Eudragit EPO granules#220432Figshare
• EPO-0411 Persistent headache attributed to ischemic stroke; impact on health-related quality of life [Abstract] / H. Weber, Markus Naumann, Dennis Freuer, Christa Meisinger, Jakob Linseisen, Michael Ertl, Lino Braadt#661678Deutsche Nationalbibliothek
• Treatment for Subjects With Chronic Kidney Disease Receiving Haemodialysis#835022ClinicalTrials.gov